Additionally, it was recently demonstrated that restoration of p53 expression and inhibition of HPV-16 E7 by CRISPR-Cas9 system delivered in nanoparticles in xenograft mice tumors induces a reduction of tumor growth and it is worth mentioning that such treatment exhibits a low toxicity and high transfection efficiency [41]. This evidence concerns the gene TP53 and neoplasm.